Cambridge firm develops new COVID-19 test
CAMBRIDGE - Biotechnology firm IES Life Sciences has responded to the global pandemic by refocusing its research from autoimmune to contagious diseases. Originally founded to resea…
CAMBRIDGE - Biotechnology firm IES Life Sciences has responded to the global pandemic by refocusing its research from autoimmune to contagious diseases. Originally founded to resea…